RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
86 hedge funds and large institutions have $475M invested in Revance Therapeutics, Inc. in 2016 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 40 increasing their positions, 19 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
49% less capital invested
Capital invested by funds: $929M → $475M (-$454M)
67% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 27
Holders
86
Holding in Top 10
3
Calls
$935K
Puts
$822K
Top Buyers
| 1 | +$19.7M | |
| 2 | +$9.54M | |
| 3 | +$2.62M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.42M |
| 5 |
JCG
JHL Capital Group
Chicago,
Illinois
|
+$1.92M |
Top Sellers
| 1 | -$19M | |
| 2 | -$12.2M | |
| 3 | -$8.99M | |
| 4 |
Renaissance Technologies
New York
|
-$7.38M |
| 5 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$3.79M |